Desq Long
Sign in

Cluster

VRXA-2026-08-27-34c4f7a52451

SEC FORM 4CLUSTER · 2 INSIDERS
$82,650.00

Veraxa Biotech AG - Post de-SPAC (VRXA)

Purchase of 55,000 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Antz Christoph Rudiger, Chief Executive OfficerPurchase of 5,000 shares at $1.53 per share.$7,650.00
  • Baumann Oliver RolfPurchase of 50,000 shares at $1.50 per share.$75,000.00

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001829126-26-009543 · filed 2026-08-31 · View filing →

Source: SEC Form 4 · 0001829126-26-009544 · filed 2026-08-31 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Veraxa Biotech AG - Post de-SPAC (VRXA)." Disclosed 2026-08-31. https://desqlong.com/cards/cluster-VRXA-2026-08-27-34c4f7a52451 (retrieved 2026-09-26).